Announcement of resolution of the second meeting of the fourth Board of Supervisors

release time:

2024-04-23 15:51

AnnouncementNumber: 2024-014

Stock code: 832316                      Securities abbreviation: Tian Zheng Biotech                Host brokerage: Shenwan Hongyuan underwriting sponsor

 

Jilin Tianzheng Biotechnology Co., Ltd

Announcement of resolution of the second meeting of the fourth Board of Supervisors

 

The Company and all members of the Board of Directors warrant that the content of the announcement is true, accurate and complete, and there are no false records, misleading statements or material omissions, and assume individual and joint legal responsibility for the authenticity, accuracy and completeness of its content.

 

1. The convening and attendance of the meeting
(1) Information on the convening of the meeting
1. Meeting Date: April 22, 2024
2. Meeting place: Conference room on the third floor of the company
3. Meeting mode: to be held on site
4. Time and manner of sending notice of the meeting of the Supervisory Board: by written notice on April 12, 2024
5. Moderator: Ms. Shi Chunyan, Chairman of the Board of Supervisors
6. Explanation of legality and compliance of the convening situation:
The convening and convening of this meeting are in accordance with the relevant provisions of the Company Law, relevant laws and regulations and the Articles of Association.
(2) Attendance at the meeting
3 supervisors shall be present at the meeting, and 3 supervisors shall be present and authorized to attend the meeting.

 

2. Deliberation of bills
(1) Deliberating and passing the motion on the "2023 Work Report of the Board of Supervisors" of the Company
1. Contents of the motion:
Report on the work of the Board of Supervisors in 2023.
2. Motion voting result: Agreed by 3 votes; Zero votes against; There were zero abstentions.
3. Recusal from voting
None.
This motion has yet to be submitted to the shareholders' meeting for consideration.

 

(2) Deliberating and adopting the motion on the Company's Final Financial Report for the Year 2023
1. Contents of the motion:
Annual Financial Report 2023.
2. Motion voting result: Agreed by 3 votes; Zero votes against; There were zero abstentions.
3. Recusal from voting
None.
This motion has yet to be submitted to the shareholders' meeting for consideration.

 

(3) Deliberating and adopting the proposal on the Company's Financial Budget Plan for 2024
1. Contents of the motion:
Financial Budget Proposal for 2024.
2. Motion voting result: Agreed by 3 votes; Zero votes against; There were zero abstentions.
3. Recusal from voting
None.
This motion has yet to be submitted to the shareholders' meeting for consideration.

 

(4) Deliberating and passing the motion on the Company's "2023 Profit Distribution Plan"
1. Contents of the motion:
In order to improve the financial robustness, enhance the ability to resist risks, achieve sustainable, stable and healthy development of the company, and better safeguard the long-term interests of all shareholders, from the actual situation of the company, the Board of directors has decided not to carry out 2023 profit distribution.
2. Motion voting result: Agreed by 3 votes; Zero votes against; There were zero abstentions.
3. Recusal from voting
None.
This motion has yet to be submitted to the shareholders' meeting for consideration.

 

(5) To consider and adopt the motion on the Company's Annual Report 2023 and Summary of the Annual Report 2023
1. Contents of the motion:
According to the Information Disclosure Rules for Listed Companies in the National SME Share Transfer System and the Notice on Disclosure of the 2023 Annual Report of Listed Companies issued by the National SME Share Transfer System Limited Liability Company, the Board of Supervisors of the Company reviewed the company's 2023 Annual Report,the review comments are as follows:
1, annual report preparation and review procedures in accordance with laws and regulations, China Securities Regulatory Commission, the national SME Share transfer system limited liability company and the company's articles of association, the company's internal management system provisions;
2. The content and format of the annual report are in line with the provisions of the Standard No. 9 on the Content and Format of Information Disclosure of Non-Listed Public Companies -- Annual Report of Listed Companies at the Innovation Level, and the information contained in the 2023 annual report of the company is not found to be inconsistent with the reality. The Company's 2023 Annual report gives a true picture of the company's operating results and financial position for the year 2023;
3. Prior to the submission of this opinion, it has not been found that the personnel involved in the preparation and review of the annual report have violated the confidentiality provisions.
In addition, all members of the Board of supervisors also attended the fifth meeting of the fourth Board of Directors of the company and performed the duties of supervisors according to law.
2. Motion voting result: Agreed by 3 votes; Zero votes against; There were zero abstentions.
3. Recusal from voting
None.
This motion has yet to be submitted to the shareholders' meeting for consideration.

 

3. File directory for reference
Resolution of the Second Meeting of the Fourth Board of Supervisors of Jilin Tianzheng Biotechnology Co., LTD.
Written Review Comments of the Board of Supervisors on the 2023 Annual Report

 

 

Jilin Tianzheng Biotechnology Co., LTD
Board of supervisors
April 22, 2024